DEMONSTRATION OF DIFFERENTIATION IN HEPATOCYTE PROGENITOR CELLS USING DIPEPTIDYL PEPTIDASE-IV DEFICIENT MUTANT RATS

被引:1
|
作者
SIGAL, SH
RAJVANSHI, P
REID, LM
GUPTA, S
机构
[1] YESHIVA UNIV ALBERT EINSTEIN COLL MED,MARION BESSIN LIVER RES CTR,BRONX,NY 10461
[2] YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MED,BRONX,NY 10461
[3] YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MOLEC PHARMACOL,BRONX,NY 10461
[4] YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MICROBIOL & IMMUNOL,BRONX,NY 10461
关键词
LIVER; PROGENITOR CELL; BIOASSAY; DPPIV; GENE EXPRESSION;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The presence of progenitor or stem cells in the adult liver and their potential roles in oncogenesis are unresolved issues. The study of hepatocyte progenitor cells has been limited by a lack of convenient in vivo systems allowing unequivocal cell localization and demonstration of differentiation into hepatocytes. To develop an in vivo progenitor bioassay, early (E14) fetal Fischer 344 rat hepatoblasts were transplanted into the spleen of syngeneic, weaning fats deficient in dipeptidyl peptidase IV (DPPIV) activity. The donor status of transplanted hepatoblasts was demonstrated by DPPIV expression. Localization of hepatoblasts was facilitated by the use of an ectopic site, as well as weanling recipients, which readily allowed identification of very small numbers of transplanted cells. Fetal rat hepatoblasts were demonstrated to undergo cellular differentiation along the hepatocyte lineage by acquiring glucose-6-phosphatase activity within 5 d of transplantation. A critical review of previous transplantation studies of hepatocyte progenitor cells and the role of the local microenvironment at inducing differentiation indicates that this novel bioassay should facilitate analysis of progenitor cells.
引用
收藏
页码:39 / 47
页数:9
相关论文
共 50 条
  • [31] Inhibition of dipeptidyl peptidase-IV enzyme activity protects against myocardial ischemia-reperfusion injury in rats
    Chua, Sarah
    Lee, Fan-Yen
    Tsai, Tzu-Hsien
    Sheu, Jiunn-Jye
    Leu, Steve
    Sun, Cheuk-Kwan
    Chen, Yung-Lung
    Chang, Hsueh-Wen
    Chai, Han-Tan
    Liu, Chu-Feng
    Lu, Hung-I
    Yip, Hon-Kan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [32] Combined treatment with a dipeptidyl peptidase-IV inhibitor (sitagliptin) and an angiotensin II type 1 receptor blocker (losartan) promotes islet regeneration via enhanced differentiation of pancreatic progenitor cells
    Liang, J.
    Leung, K. K.
    Lam, S. Y.
    Leung, P. S.
    DIABETES OBESITY & METABOLISM, 2012, 14 (09): : 842 - 851
  • [33] A KINETIC FLUOROMETRIC ASSAY OF DIPEPTIDYL PEPTIDASE-IV IN VIABLE HUMAN-BLOOD MONONUCLEAR-CELLS
    SEDO, A
    KREPELA, E
    KASAFIREK, E
    BIOCHIMIE, 1989, 71 (06) : 757 - 761
  • [34] Pharmacokinetic and pharmacodynamic profiles of SYR-322, a novel inhibitor of dipeptidyl peptidase-IV, in rats, dogs, and monkeys
    Christopher, Ronald J.
    Davenport, J. Michael
    Gwaltney, Sfephen
    Kaldor, Stephen
    Kassel, Daniel
    Lee, Bumsup
    Navre, Marc
    Shi, Lihong
    Stafford, Jeffrey
    Xu, Rongda
    Zhang, Zhiyuan
    DIABETES, 2006, 55 : A107 - A108
  • [35] Inhibition of dipeptidyl peptidase-IV enzyme activity protects against myocardial ischemia-reperfusion injury in rats
    Sarah Chua
    Fan-Yen Lee
    Tzu-Hsien Tsai
    Jiunn-Jye Sheu
    Steve Leu
    Cheuk-Kwan Sun
    Yung-Lung Chen
    Hsueh-Wen Chang
    Han-Tan Chai
    Chu-Feng Liu
    Hung-I Lu
    Hon-Kan Yip
    Journal of Translational Medicine, 12
  • [36] INCREASED SERUM LEVELS OF DIPEPTIDYL PEPTIDASE-IV (CD26) IN RATS UNDERGOING LIVER-REGENERATION
    ABBOTT, CA
    GORRELL, MD
    KOBAYASHI, Y
    KAWASAKI, T
    LIDDLE, C
    BISHOP, GA
    MCCAUGHAN, GW
    INTERNATIONAL HEPATOLOGY COMMUNICATIONS, 1995, 4 (03): : 165 - 174
  • [37] Probing prime substrate binding sites of human dipeptidyl peptidase-IV using competitive substrate approach
    Kopcho, LM
    Kim, YB
    Wang, AY
    Liu, MA
    Kirby, MS
    Marcinkeviciene, J
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2005, 436 (02) : 367 - 376
  • [38] Human pharmacokinetic profiling of the dipeptidyl peptidase-IV inhibitor teneligliptin using physiologically based pharmacokinetic modeling
    Nakamaru, Yoshinobu
    Emoto, Chie
    Shimizu, Makiko
    Yamazaki, Hiroshi
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2015, 36 (03) : 148 - 162
  • [39] INCREASED EXCRETION OF PROLINE-CONTAINING PEPTIDES IN DIPEPTIDYL PEPTIDASE IV-DEFICIENT RATS
    WATANABE, Y
    KOJIMAKOMATSU, T
    IWAKIEGAWA, S
    FUJIMOTO, Y
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1993, 81 (03): : 323 - 330
  • [40] Effect of a Dipeptidyl Peptidase-IV Inhibitor, Des-Fluoro-Sitagliptin, on Neointimal Formation after Balloon Injury in Rats
    Lim, Soo
    Choi, Sung Hee
    Shin, Hayley
    Cho, Bong Jun
    Park, Ho Seon
    Ahn, Byung Yong
    Kang, Seon Mee
    Yoon, Ji Won
    Jang, Hak Chul
    Kim, Young-Bum
    Park, Kyong Soo
    PLOS ONE, 2012, 7 (04):